与免疫检查点抑制剂相关的神经病变
Gabriel de Deus Vieira1, Vinícius de Oliveira Boldrini2, Luana Schlindwen3
1Brazilian Institute of Neuroscience and Neurotechnology, University of Campinas, Campinas, Brazil; Department of Neurology, University of the Joinville Region, Joinville, Brazil.
Journal of neuroimmunology
|September 16, 2025
概括
免疫检查点抑制剂 (ICI) 通过增强免疫细胞来治疗癌症,但可以引起神经系统的副作用. 本综述侧重于接受ICI癌症治疗的患者的头骨神经问题.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 神经学 神经学
背景情况:
- 作为免疫检查点抑制剂 (ICI),单克隆抗体 (mAbs) 是一种关键的癌症治疗方法.
- 通过逆转T细胞和NK细胞耗尽,ICI可以增强抗瘤免疫力.
- 治疗ICI可能会导致与免疫相关的不良事件,影响各种器官,包括神经系统.
研究的目的:
- 在接受ICI治疗的癌症患者中,审查神经干扰作为神经系统病变的表现.
主要方法:
- 关于免疫检查点抑制剂和神经系统不良事件的研究文献综述.
- 专注于病例报告和详细介绍神经神经病变的临床研究.
主要成果:
- 神经干扰是ICI治疗中已知的神经复杂症.
- 这些事件表现为神经系统内的特定病变.
- 了解这些模式有助于诊断和管理.
结论:
- 免疫检查点抑制剂提供向癌症治疗,但存在神经系统不良事件的风险.
- 神经受影响是ICI诱导的神经毒性的显著表现.
- 需要进一步研究以阐明这些并发症的机制并优化这些并发症的管理.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
589
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
589
Autoimmune Disorders
1.5K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.5K


